BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

BACKGROUND: BRCC3 has been found to be aberrantly expressed in breast tumors and involved in DNA damage response. The contribution of BRCC3 to nasopharyngeal carcinoma prognosis and radiosensitivity is still unclear. METHODS: Immunohistochemical analysis of BRCC3 was carried out in 100 nasopharyngea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Tu, Ziwei, Xu, Bingqing, Qu, Chen, Tao, Yalan, Chen, Chen, Hua, Wenfeng, Feng, Guokai, Chang, Hui, Liu, Zhigang, Li, Guo, Jiang, Changbin, Yi, Wei, Zeng, Musheng, Xia, Yunfei
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511524/
https://ncbi.nlm.nih.gov/pubmed/26024915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-015-0427-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados